title: Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients.
abstract: K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.
authors.affiliation: Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC. Electronic address: brclark@childrensnational.org.
authors.forename: Bradley C
authors.initials: BC
authors.lastname: Clark
authors.affiliation: Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
authors.forename: Justin
authors.initials: J
authors.lastname: Georgekutty
authors.affiliation: Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
authors.forename: Charles I
authors.initials: CI
authors.lastname: Berul
mesh_terms: D000293:Adolescent; D002186:Cannabinoids / Q000009:adverse effects*; D015198:Designer Drugs / Q000009:adverse effects*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000139:chemically induced*; D013616:Tachycardia, Sinus / Q000139:chemically induced; D019210:Troponin I / Q000097:blood
chemical_list: D002186:Cannabinoids; D015198:Designer Drugs; D019210:Troponin I